Clinical Trials List
Protocol NumberP1101.HCC
Active
2018-03-31 - 2026-04-20
Phase I/II
Recruiting1
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- JA-DER LIANG Division of General Internal Medicine
- Ming-Chih Ho Division of General Surgery
- 曾岱宗 Division of General Internal Medicine
- Chun-Jen Liu Division of General Internal Medicine
- REY-HENG HU Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
84 participants
-
Global
84 participants
